eprosartan
angiotensin II receptor antagonist used for the treatment of high blood pressure.
üksikjuht nähtusest
type of chemical entity
mille alamklass
kasutus
keemiline struktuur
mass/kaal
424,146 aatommassiühik[3]
chemical formula
C₂₃H₂₄N₂O₄S[3]
canonical SMILES
CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O[3]
isomeric SMILES
CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O[3]
defined daily dose
World Health Organisation international non-proprietary name
eprosartan[6]
significant drug interaction
physically interacts with
LiverTox likelihood score
LiverTox toxicity likelihood category E*[24]
Commonsi kategooria
Eprosartan
Viited
- ↑ 1,0 1,1 1,2 1,3 1,4 Global Substance Registration System, 18. november 2016, inglise keel, eprosartan, 2KH13Z0S0Y
- ↑ CAS Common Chemistry, 9. aprill 2021, OROAFUQRIXKEMV-LDADJPATSA-N, https://commonchemistry.cas.org/detail?cas_rn=133040-01-4
- ↑ 3,0 3,1 3,2 3,3 3,4 3,5 3,6 PubChem, 18. november 2016, inglise keel, 5281037, 133040-01-4
- ↑ 4,0 4,1 4,2 4,3 4,4 4,5 OROAFUQRIXKEMV-LDADJPATSA-N, InChIKey
- ↑ 5,0 5,1 UniChem
- ↑ 6,0 6,1 6,2 6,3 ChEBI, 3. oktoober 2016, inglise keel, eprosartan, 4814
- ↑ 7,0 7,1 ChEMBL, 18. november 2016, inglise keel, EPROSARTAN, CHEMBL813
- ↑ ChEBI release 2020-09-01
- ↑ International Chemical Identifier, InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+
- ↑ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
- ↑ DrugBank, inglise keel, 17. november 2015, 00876, Eprosartan
- ↑ 12,0 12,1 inferred from InChIKey
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 18. november 2016, inglise keel, 588, eprosartan
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 5. veebruar 2021
- ↑ Hazardous Substances Data Bank, 10. mai 2021, 28. oktoober 2019, EPROSARTAN, 7521
- ↑ Freebase Data Dumps, 28. oktoober 2013
- ↑ ChemSpider, 18. november 2016, inglise keel, 4444504, Eprosartan
- ↑ Medical Subject Headings, 14. märts 2018, C068373
- ↑ https://www.whocc.no/atc_ddd_index/?code=C09CA02
- ↑ 20,0 20,1 N0000148645, 13. detsember 2016, NDF-RT, inglise keel
- ↑ 21,00 21,01 21,02 21,03 21,04 21,05 21,06 21,07 21,08 21,09 21,10 21,11 21,12 21,13 21,14 21,15 21,16 21,17 21,18 21,19 21,20 21,21 21,22 21,23 21,24 21,25 21,26 21,27 21,28 21,29 21,30 21,31 21,32 21,33 21,34 21,35 21,36 21,37 21,38 21,39 21,40 21,41 21,42 21,43 21,44 21,45 21,46 21,47 21,48 21,49 21,50 21,51 21,52 21,53 21,54 21,55 21,56 21,57 21,58 21,59 21,60 21,61 21,62 21,63 21,64 21,65 21,66 21,67 21,68 21,69 21,70 21,71 21,72 21,73 21,74 21,75 21,76 21,77 21,78 21,79 21,80 21,81 21,82 21,83 21,84 A reference set of clinically relevant adverse drug-drug interactions, established
- ↑ A reference set of clinically relevant adverse drug-drug interactions, hypothetically
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 588, inglise keel
- ↑ LiverTox, 8. aprill 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Eprosartan, 13. jaanuar 2017
- ↑ 25,0 25,1 Medical Subject Headings, 15. märts 2018, C068373